title: Combination Products And the FDA: Issues and Answers.
abstract: For products that combine a drug with a device, such as a drug-eluting stent, the regulatory pathway is less clear than it is for drugs or devices alone. The authors discuss the steps that the FDA has taken to address this situation.
authors: Howard
authors: H
authors: Manresa
authors: Arlen D
authors: AD
authors: Meyers